Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders

Authors

Maribel Vazquez, National Institutes of Health
Jack Chovanec, National Institutes of Health
Jiwon Kim, National Institutes of Health
Thomas DiMaggio, National Institutes of Health
Joshua D Milner, Columbia University
Clair A Francomano, Indiana University
Christina A Gurnett, Washington University School of Medicine in St. Louis
Marco Ritelli, University of Brescia
Marina Colombi, University of Brescia
Jonathan J Lyons, National Institutes of Health

Journal

HGG Advances

Publication Date

4-14-2022

Volume

3

Issue

2

First Page

100094

Document Type

Open Access Publication

DOI

10.1016/j.xhgg.2022.100094

Rights and Permissions

Vazquez M, Chovanec J, Kim J, DiMaggio T, Milner JD, Francomano CA, Gurnett CA, Ritelli M, Colombi M, Lyons JJ. Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders. HGG Adv. 2022 Feb 22;3(2):100094. doi.org/10.1016/j.xhgg.2022.100094. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Vazquez, Maribel; Chovanec, Jack; Kim, Jiwon; DiMaggio, Thomas; Milner, Joshua D; Francomano, Clair A; Gurnett, Christina A; Ritelli, Marco; Colombi, Marina; and Lyons, Jonathan J, "Hereditary alpha-tryptasemia modifies clinical phenotypes among individuals with congenital hypermobility disorders." HGG Advances. 3, 2. 100094 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11652